Biotech
- Date: Sep 15, 2017
- Category: Biotech
CHIPSA Hospital Files Patent On Coley’s Immunotherapy With Checkpoint Inhibitors
CHIPSA Hospital, dedicated to the accelerated development of nontoxic cancer immunotherapies announced today filing of a patent application covering the combination of FDA approved antibodies known as “checkpoint inhibitors” together with Coley Vaccine, a stimulatory of innate immunity. CHIPSA is the only licensed hospital facility (under doctor supervision) treating with the Coley’s Vaccine in North America. The patent was based on animal data using the established B16 melanoma mouse model, as well as patient cases. Continue reading
- — Listed in: Biotech
- — Tagged: cancer drugs, cancer patent, cancer vaccine, coleys vaccine, immunotherapy
- Read more
- Date: Oct 17, 2013
- Category: Biotech
SOBERLINK Is Not Just Another Breathalyzer
SOBERLINK is a new alcohol monitoring system that is different from all other breathalyzers. With SOBERLINK, individuals can self-test and comprehensively track their sobriety to comply with personal or mandated requirements in a way that is unavailable with standard breathalzyers. Continue reading